cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sera Prognostics Inc A
4 own
6 watching
Current Price
$9.79
$0.11
(1.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
187.09M
52-Week High
52-Week High
11.32000
52-Week Low
52-Week Low
1.52000
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization187.09M
icon52-Week High11.32000
icon52-Week Low1.52000
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Sera Prognostics Inc A do?
Sera Prognostics, Inc., a women s health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Read More
How much money does Sera Prognostics Inc A make?
News & Events about Sera Prognostics Inc A.
PR Newswire
1 year ago
Thinking about buying stock in Palantir Technologies, Sera Prognostics, Transcode Therapeutics, Sorrento Therapeutics, or Marathon Digital? Thinking about buying stock in Palantir Technologies, Sera Prognostics, Transcode Therapeutics, Sorrento Therapeutics, or Marathon Digital? PR Newswire NEW...
PR Newswire
1 year ago
SONRAVA HEALTH TO INCLUDE THE PreTRM TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS SONRAVA HEALTH TO INCLUDE THE PreTRM TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS PR Newswire SALT LAKE...
PR Newswire
1 year ago
SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE PR Newswire SALT LAKE CITY, June 6, 2022 SALT LAKE CITY, June 6, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy...
PR Newswire
1 year ago
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 PR Newswire SALT LAKE CITY, May 2, 2022 SALT LAKE CITY, May 2...
PR Newswire
2years ago
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting PR Newswire...
Frequently Asked Questions
Frequently Asked Questions
What is Sera Prognostics Inc A share price today?
plus_minus_icon
Can Indians buy Sera Prognostics Inc A shares?
plus_minus_icon
How can I buy Sera Prognostics Inc A shares from India?
plus_minus_icon
Can Fractional shares of Sera Prognostics Inc A be purchased?
plus_minus_icon
What are the documents required to start investing in Sera Prognostics Inc A stocks?
plus_minus_icon
What is today’s traded volume of Sera Prognostics Inc A?
plus_minus_icon
What is today’s market capitalisation of Sera Prognostics Inc A?
plus_minus_icon
What is the 52-Week High and Low Range of Sera Prognostics Inc A?
plus_minus_icon
What percentage is Sera Prognostics Inc A down from its 52-Week High?
plus_minus_icon
What percentage is Sera Prognostics Inc A up from its 52-Week Low?
plus_minus_icon
Current Price
$9.79
$0.11
(1.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00